mesowatch
Largest Recorded Individual Lawsuit For Asbestos
divider

Largest Recorded Individual Lawsuit For Asbestos Exposure Awarded To Mississippi Man

Largest Recorded Individual Lawsuit For Asbestos Exposure Awarded To Mississippi Man

Matthew Davis

Reading Time: 2 mins

Last Modified: January 11, 2017

Matthew Davis - author

Matthew Davis is a freelance journalist who has covered civil litigation for a variety of publications. He joined Mesowatch in 2016 and covers asbestos litigation developments in the U.S., as well as newsworthy asbestos cases.

More to Read

divider

May 10, 2024

EPA’s Asbestos Ban: Not Enough to End Cancer for Workers

>READ

divider

May 8, 2024

The $6.5 Billion Question: What’s Next for Ovarian Cancer Claims

>READ

divider

May 3, 2024

Illinois Jury Awards $45M in J&J Baby Powder Case

>READ

divider

May 2, 2024

Revolutionizing Mesothelioma Care: New Treatment Era with ADI-PEG20

>READ

divider

April 22, 2024

Miami Judge Declares Mistrial in Ovarian Cancer Case filed against J&J talc

>READ

divider

April 8, 2024

Florida Jury Hears Opening Statements Against Johnson & Johnson

>READ

divider

Want to Contribute Breaking News?

To contribute to our constant feed of relevant legal matters

News & Data

divider

FILTER:

search
divider
Jury Awards $15M in Mesothelioma Verdict Against R.T. Vanderbilt
Jury Awards $15M in Mesothelioma Verdict Against R.T. Vanderbilt

Mary Pieper
2 mins read - May 17, 2024

A jury has handed up a verdict of $15 million against R.T. Vanderbilt Holding Company Inc. on behalf of the family of a man who died of mesothelioma following asbestos...

Settlements

Court Doubles Pabst’s Mesothelioma Payout to $13.4M
Court Doubles Pabst’s Mesothelioma Payout to $13.4M

Mary Pieper
2 mins read - May 17, 2024

The Wisconsin Court of Appeals has increased the award from $6.9 million to $13.4 million for the family of a steamfitter who died of mesothelioma in 2018 due to asbestos exposure...

Settlements

Harvard Study Offers Hope for Women with Pleural Mesothelioma
Harvard Study Offers Hope for Women with Pleural Mesothelioma

Mary Pieper
2 mins read - May 14, 2024

A recent study led by researchers at Harvard Medical School suggests women with pleural mesothelioma (PM) who undergo a lung-sparing surgery called intended extended pleurectomy...

Treatment

EPA’s Asbestos Ban: Not Enough to End Cancer for Workers
EPA’s Asbestos Ban: Not Enough to End Cancer for Workers

Mary Pieper
5 mins read - May 10, 2024

Although the U.S. Environmental Protection Agency recently banned chrysolite, the last known type of asbestos imported into the United States, union officials and health and...

Exposure Bans

The $6.5 Billion Question: What’s Next for Ovarian Cancer Claims
The $6.5 Billion Question: What’s Next for Ovarian Cancer Claims

Melissa Bill
4 mins read - May 8, 2024

Johnson & Johnson is on the verge of settling more than 50,000 lawsuits alleging that the use of its widely-used talc baby powder led to claimants developing ovarian cancer....

Settlements

Illinois Jury Awards $45M in J&J Baby Powder Case
Illinois Jury Awards $45M in J&J Baby Powder Case

Melissa Bill
3 mins read - May 3, 2024

On Friday, an Illinois court ordered Johnson & Johnson and Kenvue to pay $45 million in a case that involved a family that alleged a link between the relative’s death after...

Settlements


May 2, 2024

Revolutionizing Mesothelioma Care: New Treatment Era with ADI-PEG20

>READ

divider

April 22, 2024

Miami Judge Declares Mistrial in Ovarian Cancer Case filed against J&J talc

>READ

divider

April 8, 2024

Florida Jury Hears Opening Statements Against Johnson & Johnson

>READ

divider

March 18, 2024

Historic Victory: EPA Seals the Fate of Asbestos in America

>READ

divider

February 26, 2024

Healing Heroes: Expanding VA Support for Asbestos-Exposed Veterans

>READ

divider

February 1, 2024

Talc Producer Proposes $862.5M Trust to Settle Cancer Claims

>READ

divider

January 24, 2024

The Cost of Powder: J&J’s $700 Million Leap to Settle Asbestos Cancer Claims

>READ

divider

December 24, 2023

Groundbreaking Therapy Enhances Lifespan in Mesothelioma Trials

>READ

divider

December 12, 2023

American International Appeals Subpoena Ruling in Talc Mesothelioma Case

>READ

divider

Want to Contribute Breaking News?

To contribute to our constant feed of relevant legal matters

Information provided by Mesowatch aims to provide legal and financial assistance and should not be considered a substitute for medical advice, treatment or diagnosis. Past performance and settlements do not guarantee or indicate the outcome of an individual case. Viewing this information or interacting with this website does not create an attorney-client relationship.